Global In-Vitro Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Page: 124
Published Date: 19 Jul 2023
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global In-Vitro Diagnostics market size was valued at USD 108180 million in 2022 and is forecast to a readjusted size of USD 150050 million by 2029 with a CAGR of 4.8% during review period.
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.
The concentration of the market is relatively high, and the top 10 companies include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Becton Dickinson, BioMerieux, Sysmex, Hologic, Ortho Clinical Diagnostics, they occupied about 70% of whole market. North America dominates the market which occupied 41.39% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 15.74% of the whole market.
The Global Info Research report includes an overview of the development of the In-Vitro Diagnostics industry chain, the market status of Diabetes (Tissue Diagnostics, Professional Diagnostic), Infectious Diseases (Tissue Diagnostics, Professional Diagnostic), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of In-Vitro Diagnostics.
Regionally, the report analyzes the In-Vitro Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global In-Vitro Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the In-Vitro Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the In-Vitro Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Tissue Diagnostics, Professional Diagnostic).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the In-Vitro Diagnostics market.
Regional Analysis: The report involves examining the In-Vitro Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the In-Vitro Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to In-Vitro Diagnostics:
Company Analysis: Report covers individual In-Vitro Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards In-Vitro Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Diabetes, Infectious Diseases).
Technology Analysis: Report covers specific technologies relevant to In-Vitro Diagnostics. It assesses the current state, advancements, and potential future developments in In-Vitro Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the In-Vitro Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
In-Vitro Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Other
Market segment by Application
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
Market segment by players, this report covers
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
LifeScan
Qiagen
Wuhan Easy Diagnosis
Wondfo
KHB
Hotgen
Mindray
Sinocare
Getein Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe In-Vitro Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of In-Vitro Diagnostics, with revenue, gross margin and global market share of In-Vitro Diagnostics from 2018 to 2023.
Chapter 3, the In-Vitro Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and In-Vitro Diagnostics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of In-Vitro Diagnostics.
Chapter 13, to describe In-Vitro Diagnostics research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of In-Vitro Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of In-Vitro Diagnostics by Type
1.3.1 Overview: Global In-Vitro Diagnostics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global In-Vitro Diagnostics Consumption Value Market Share by Type in 2022
1.3.3 Tissue Diagnostics
1.3.4 Professional Diagnostic
1.3.5 Molecular Diagnostic
1.3.6 Diabetes Monitoring
1.3.7 Other
1.4 Global In-Vitro Diagnostics Market by Application
1.4.1 Overview: Global In-Vitro Diagnostics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Diabetes
1.4.3 Infectious Diseases
1.4.4 Oncology
1.4.5 Cardiology
1.4.6 HIV
1.4.7 Other
1.5 Global In-Vitro Diagnostics Market Size & Forecast
1.6 Global In-Vitro Diagnostics Market Size and Forecast by Region
1.6.1 Global In-Vitro Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global In-Vitro Diagnostics Market Size by Region, (2018-2029)
1.6.3 North America In-Vitro Diagnostics Market Size and Prospect (2018-2029)
1.6.4 Europe In-Vitro Diagnostics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific In-Vitro Diagnostics Market Size and Prospect (2018-2029)
1.6.6 South America In-Vitro Diagnostics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa In-Vitro Diagnostics Market Size and Prospect (2018-2029)
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche In-Vitro Diagnostics Product and Solutions
2.1.4 Roche In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott In-Vitro Diagnostics Product and Solutions
2.2.4 Abbott In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbott Recent Developments and Future Plans
2.3 Danaher
2.3.1 Danaher Details
2.3.2 Danaher Major Business
2.3.3 Danaher In-Vitro Diagnostics Product and Solutions
2.3.4 Danaher In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Danaher Recent Developments and Future Plans
2.4 Siemens Healthineers
2.4.1 Siemens Healthineers Details
2.4.2 Siemens Healthineers Major Business
2.4.3 Siemens Healthineers In-Vitro Diagnostics Product and Solutions
2.4.4 Siemens Healthineers In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Siemens Healthineers Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific In-Vitro Diagnostics Product and Solutions
2.5.4 Thermo Fisher Scientific In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 Sysmex
2.6.1 Sysmex Details
2.6.2 Sysmex Major Business
2.6.3 Sysmex In-Vitro Diagnostics Product and Solutions
2.6.4 Sysmex In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sysmex Recent Developments and Future Plans
2.7 BioMerieux
2.7.1 BioMerieux Details
2.7.2 BioMerieux Major Business
2.7.3 BioMerieux In-Vitro Diagnostics Product and Solutions
2.7.4 BioMerieux In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 BioMerieux Recent Developments and Future Plans
2.8 Ortho Clinical Diagnostics
2.8.1 Ortho Clinical Diagnostics Details
2.8.2 Ortho Clinical Diagnostics Major Business
2.8.3 Ortho Clinical Diagnostics In-Vitro Diagnostics Product and Solutions
2.8.4 Ortho Clinical Diagnostics In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
2.9 Becton Dickinson
2.9.1 Becton Dickinson Details
2.9.2 Becton Dickinson Major Business
2.9.3 Becton Dickinson In-Vitro Diagnostics Product and Solutions
2.9.4 Becton Dickinson In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Becton Dickinson Recent Developments and Future Plans
2.10 Bio-Rad Laboratories
2.10.1 Bio-Rad Laboratories Details
2.10.2 Bio-Rad Laboratories Major Business
2.10.3 Bio-Rad Laboratories In-Vitro Diagnostics Product and Solutions
2.10.4 Bio-Rad Laboratories In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.11 Hologic
2.11.1 Hologic Details
2.11.2 Hologic Major Business
2.11.3 Hologic In-Vitro Diagnostics Product and Solutions
2.11.4 Hologic In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hologic Recent Developments and Future Plans
2.12 LifeScan
2.12.1 LifeScan Details
2.12.2 LifeScan Major Business
2.12.3 LifeScan In-Vitro Diagnostics Product and Solutions
2.12.4 LifeScan In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 LifeScan Recent Developments and Future Plans
2.13 Qiagen
2.13.1 Qiagen Details
2.13.2 Qiagen Major Business
2.13.3 Qiagen In-Vitro Diagnostics Product and Solutions
2.13.4 Qiagen In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Qiagen Recent Developments and Future Plans
2.14 Wuhan Easy Diagnosis
2.14.1 Wuhan Easy Diagnosis Details
2.14.2 Wuhan Easy Diagnosis Major Business
2.14.3 Wuhan Easy Diagnosis In-Vitro Diagnostics Product and Solutions
2.14.4 Wuhan Easy Diagnosis In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Wuhan Easy Diagnosis Recent Developments and Future Plans
2.15 Wondfo
2.15.1 Wondfo Details
2.15.2 Wondfo Major Business
2.15.3 Wondfo In-Vitro Diagnostics Product and Solutions
2.15.4 Wondfo In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Wondfo Recent Developments and Future Plans
2.16 KHB
2.16.1 KHB Details
2.16.2 KHB Major Business
2.16.3 KHB In-Vitro Diagnostics Product and Solutions
2.16.4 KHB In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 KHB Recent Developments and Future Plans
2.17 Hotgen
2.17.1 Hotgen Details
2.17.2 Hotgen Major Business
2.17.3 Hotgen In-Vitro Diagnostics Product and Solutions
2.17.4 Hotgen In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Hotgen Recent Developments and Future Plans
2.18 Mindray
2.18.1 Mindray Details
2.18.2 Mindray Major Business
2.18.3 Mindray In-Vitro Diagnostics Product and Solutions
2.18.4 Mindray In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Mindray Recent Developments and Future Plans
2.19 Sinocare
2.19.1 Sinocare Details
2.19.2 Sinocare Major Business
2.19.3 Sinocare In-Vitro Diagnostics Product and Solutions
2.19.4 Sinocare In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Sinocare Recent Developments and Future Plans
2.20 Getein Biotech
2.20.1 Getein Biotech Details
2.20.2 Getein Biotech Major Business
2.20.3 Getein Biotech In-Vitro Diagnostics Product and Solutions
2.20.4 Getein Biotech In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Getein Biotech Recent Developments and Future Plans
3.1 Global In-Vitro Diagnostics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of In-Vitro Diagnostics by Company Revenue
3.2.2 Top 3 In-Vitro Diagnostics Players Market Share in 2022
3.2.3 Top 6 In-Vitro Diagnostics Players Market Share in 2022
3.3 In-Vitro Diagnostics Market: Overall Company Footprint Analysis
3.3.1 In-Vitro Diagnostics Market: Region Footprint
3.3.2 In-Vitro Diagnostics Market: Company Product Type Footprint
3.3.3 In-Vitro Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global In-Vitro Diagnostics Consumption Value and Market Share by Type (2018-2023)
4.2 Global In-Vitro Diagnostics Market Forecast by Type (2024-2029)
5.1 Global In-Vitro Diagnostics Consumption Value Market Share by Application (2018-2023)
5.2 Global In-Vitro Diagnostics Market Forecast by Application (2024-2029)
6.1 North America In-Vitro Diagnostics Consumption Value by Type (2018-2029)
6.2 North America In-Vitro Diagnostics Consumption Value by Application (2018-2029)
6.3 North America In-Vitro Diagnostics Market Size by Country
6.3.1 North America In-Vitro Diagnostics Consumption Value by Country (2018-2029)
6.3.2 United States In-Vitro Diagnostics Market Size and Forecast (2018-2029)
6.3.3 Canada In-Vitro Diagnostics Market Size and Forecast (2018-2029)
6.3.4 Mexico In-Vitro Diagnostics Market Size and Forecast (2018-2029)
7.1 Europe In-Vitro Diagnostics Consumption Value by Type (2018-2029)
7.2 Europe In-Vitro Diagnostics Consumption Value by Application (2018-2029)
7.3 Europe In-Vitro Diagnostics Market Size by Country
7.3.1 Europe In-Vitro Diagnostics Consumption Value by Country (2018-2029)
7.3.2 Germany In-Vitro Diagnostics Market Size and Forecast (2018-2029)
7.3.3 France In-Vitro Diagnostics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom In-Vitro Diagnostics Market Size and Forecast (2018-2029)
7.3.5 Russia In-Vitro Diagnostics Market Size and Forecast (2018-2029)
7.3.6 Italy In-Vitro Diagnostics Market Size and Forecast (2018-2029)
8.1 Asia-Pacific In-Vitro Diagnostics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific In-Vitro Diagnostics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific In-Vitro Diagnostics Market Size by Region
8.3.1 Asia-Pacific In-Vitro Diagnostics Consumption Value by Region (2018-2029)
8.3.2 China In-Vitro Diagnostics Market Size and Forecast (2018-2029)
8.3.3 Japan In-Vitro Diagnostics Market Size and Forecast (2018-2029)
8.3.4 South Korea In-Vitro Diagnostics Market Size and Forecast (2018-2029)
8.3.5 India In-Vitro Diagnostics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia In-Vitro Diagnostics Market Size and Forecast (2018-2029)
8.3.7 Australia In-Vitro Diagnostics Market Size and Forecast (2018-2029)
9.1 South America In-Vitro Diagnostics Consumption Value by Type (2018-2029)
9.2 South America In-Vitro Diagnostics Consumption Value by Application (2018-2029)
9.3 South America In-Vitro Diagnostics Market Size by Country
9.3.1 South America In-Vitro Diagnostics Consumption Value by Country (2018-2029)
9.3.2 Brazil In-Vitro Diagnostics Market Size and Forecast (2018-2029)
9.3.3 Argentina In-Vitro Diagnostics Market Size and Forecast (2018-2029)
10.1 Middle East & Africa In-Vitro Diagnostics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa In-Vitro Diagnostics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa In-Vitro Diagnostics Market Size by Country
10.3.1 Middle East & Africa In-Vitro Diagnostics Consumption Value by Country (2018-2029)
10.3.2 Turkey In-Vitro Diagnostics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia In-Vitro Diagnostics Market Size and Forecast (2018-2029)
10.3.4 UAE In-Vitro Diagnostics Market Size and Forecast (2018-2029)
11.1 In-Vitro Diagnostics Market Drivers
11.2 In-Vitro Diagnostics Market Restraints
11.3 In-Vitro Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12.1 In-Vitro Diagnostics Industry Chain
12.2 In-Vitro Diagnostics Upstream Analysis
12.3 In-Vitro Diagnostics Midstream Analysis
12.4 In-Vitro Diagnostics Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global In-Vitro Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global In-Vitro Diagnostics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global In-Vitro Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global In-Vitro Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche In-Vitro Diagnostics Product and Solutions
Table 8. Roche In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Abbott Company Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott In-Vitro Diagnostics Product and Solutions
Table 13. Abbott In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Abbott Recent Developments and Future Plans
Table 15. Danaher Company Information, Head Office, and Major Competitors
Table 16. Danaher Major Business
Table 17. Danaher In-Vitro Diagnostics Product and Solutions
Table 18. Danaher In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Danaher Recent Developments and Future Plans
Table 20. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 21. Siemens Healthineers Major Business
Table 22. Siemens Healthineers In-Vitro Diagnostics Product and Solutions
Table 23. Siemens Healthineers In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Siemens Healthineers Recent Developments and Future Plans
Table 25. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 26. Thermo Fisher Scientific Major Business
Table 27. Thermo Fisher Scientific In-Vitro Diagnostics Product and Solutions
Table 28. Thermo Fisher Scientific In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Thermo Fisher Scientific Recent Developments and Future Plans
Table 30. Sysmex Company Information, Head Office, and Major Competitors
Table 31. Sysmex Major Business
Table 32. Sysmex In-Vitro Diagnostics Product and Solutions
Table 33. Sysmex In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Sysmex Recent Developments and Future Plans
Table 35. BioMerieux Company Information, Head Office, and Major Competitors
Table 36. BioMerieux Major Business
Table 37. BioMerieux In-Vitro Diagnostics Product and Solutions
Table 38. BioMerieux In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. BioMerieux Recent Developments and Future Plans
Table 40. Ortho Clinical Diagnostics Company Information, Head Office, and Major Competitors
Table 41. Ortho Clinical Diagnostics Major Business
Table 42. Ortho Clinical Diagnostics In-Vitro Diagnostics Product and Solutions
Table 43. Ortho Clinical Diagnostics In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Ortho Clinical Diagnostics Recent Developments and Future Plans
Table 45. Becton Dickinson Company Information, Head Office, and Major Competitors
Table 46. Becton Dickinson Major Business
Table 47. Becton Dickinson In-Vitro Diagnostics Product and Solutions
Table 48. Becton Dickinson In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Becton Dickinson Recent Developments and Future Plans
Table 50. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 51. Bio-Rad Laboratories Major Business
Table 52. Bio-Rad Laboratories In-Vitro Diagnostics Product and Solutions
Table 53. Bio-Rad Laboratories In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Bio-Rad Laboratories Recent Developments and Future Plans
Table 55. Hologic Company Information, Head Office, and Major Competitors
Table 56. Hologic Major Business
Table 57. Hologic In-Vitro Diagnostics Product and Solutions
Table 58. Hologic In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Hologic Recent Developments and Future Plans
Table 60. LifeScan Company Information, Head Office, and Major Competitors
Table 61. LifeScan Major Business
Table 62. LifeScan In-Vitro Diagnostics Product and Solutions
Table 63. LifeScan In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. LifeScan Recent Developments and Future Plans
Table 65. Qiagen Company Information, Head Office, and Major Competitors
Table 66. Qiagen Major Business
Table 67. Qiagen In-Vitro Diagnostics Product and Solutions
Table 68. Qiagen In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Qiagen Recent Developments and Future Plans
Table 70. Wuhan Easy Diagnosis Company Information, Head Office, and Major Competitors
Table 71. Wuhan Easy Diagnosis Major Business
Table 72. Wuhan Easy Diagnosis In-Vitro Diagnostics Product and Solutions
Table 73. Wuhan Easy Diagnosis In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Wuhan Easy Diagnosis Recent Developments and Future Plans
Table 75. Wondfo Company Information, Head Office, and Major Competitors
Table 76. Wondfo Major Business
Table 77. Wondfo In-Vitro Diagnostics Product and Solutions
Table 78. Wondfo In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Wondfo Recent Developments and Future Plans
Table 80. KHB Company Information, Head Office, and Major Competitors
Table 81. KHB Major Business
Table 82. KHB In-Vitro Diagnostics Product and Solutions
Table 83. KHB In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. KHB Recent Developments and Future Plans
Table 85. Hotgen Company Information, Head Office, and Major Competitors
Table 86. Hotgen Major Business
Table 87. Hotgen In-Vitro Diagnostics Product and Solutions
Table 88. Hotgen In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Hotgen Recent Developments and Future Plans
Table 90. Mindray Company Information, Head Office, and Major Competitors
Table 91. Mindray Major Business
Table 92. Mindray In-Vitro Diagnostics Product and Solutions
Table 93. Mindray In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Mindray Recent Developments and Future Plans
Table 95. Sinocare Company Information, Head Office, and Major Competitors
Table 96. Sinocare Major Business
Table 97. Sinocare In-Vitro Diagnostics Product and Solutions
Table 98. Sinocare In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Sinocare Recent Developments and Future Plans
Table 100. Getein Biotech Company Information, Head Office, and Major Competitors
Table 101. Getein Biotech Major Business
Table 102. Getein Biotech In-Vitro Diagnostics Product and Solutions
Table 103. Getein Biotech In-Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Getein Biotech Recent Developments and Future Plans
Table 105. Global In-Vitro Diagnostics Revenue (USD Million) by Players (2018-2023)
Table 106. Global In-Vitro Diagnostics Revenue Share by Players (2018-2023)
Table 107. Breakdown of In-Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in In-Vitro Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 109. Head Office of Key In-Vitro Diagnostics Players
Table 110. In-Vitro Diagnostics Market: Company Product Type Footprint
Table 111. In-Vitro Diagnostics Market: Company Product Application Footprint
Table 112. In-Vitro Diagnostics New Market Entrants and Barriers to Market Entry
Table 113. In-Vitro Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global In-Vitro Diagnostics Consumption Value (USD Million) by Type (2018-2023)
Table 115. Global In-Vitro Diagnostics Consumption Value Share by Type (2018-2023)
Table 116. Global In-Vitro Diagnostics Consumption Value Forecast by Type (2024-2029)
Table 117. Global In-Vitro Diagnostics Consumption Value by Application (2018-2023)
Table 118. Global In-Vitro Diagnostics Consumption Value Forecast by Application (2024-2029)
Table 119. North America In-Vitro Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 120. North America In-Vitro Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 121. North America In-Vitro Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 122. North America In-Vitro Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 123. North America In-Vitro Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 124. North America In-Vitro Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 125. Europe In-Vitro Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 126. Europe In-Vitro Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 127. Europe In-Vitro Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 128. Europe In-Vitro Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 129. Europe In-Vitro Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe In-Vitro Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific In-Vitro Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 132. Asia-Pacific In-Vitro Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 133. Asia-Pacific In-Vitro Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 134. Asia-Pacific In-Vitro Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 135. Asia-Pacific In-Vitro Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 136. Asia-Pacific In-Vitro Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
Table 137. South America In-Vitro Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 138. South America In-Vitro Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 139. South America In-Vitro Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 140. South America In-Vitro Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 141. South America In-Vitro Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 142. South America In-Vitro Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 143. Middle East & Africa In-Vitro Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 144. Middle East & Africa In-Vitro Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 145. Middle East & Africa In-Vitro Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 146. Middle East & Africa In-Vitro Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 147. Middle East & Africa In-Vitro Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 148. Middle East & Africa In-Vitro Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 149. In-Vitro Diagnostics Raw Material
Table 150. Key Suppliers of In-Vitro Diagnostics Raw Materials
List of Figures
Figure 1. In-Vitro Diagnostics Picture
Figure 2. Global In-Vitro Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global In-Vitro Diagnostics Consumption Value Market Share by Type in 2022
Figure 4. Tissue Diagnostics
Figure 5. Professional Diagnostic
Figure 6. Molecular Diagnostic
Figure 7. Diabetes Monitoring
Figure 8. Other
Figure 9. Global In-Vitro Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. In-Vitro Diagnostics Consumption Value Market Share by Application in 2022
Figure 11. Diabetes Picture
Figure 12. Infectious Diseases Picture
Figure 13. Oncology Picture
Figure 14. Cardiology Picture
Figure 15. HIV Picture
Figure 16. Other Picture
Figure 17. Global In-Vitro Diagnostics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global In-Vitro Diagnostics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Market In-Vitro Diagnostics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 20. Global In-Vitro Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 21. Global In-Vitro Diagnostics Consumption Value Market Share by Region in 2022
Figure 22. North America In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 25. South America In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East and Africa In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 27. Global In-Vitro Diagnostics Revenue Share by Players in 2022
Figure 28. In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 29. Global Top 3 Players In-Vitro Diagnostics Market Share in 2022
Figure 30. Global Top 6 Players In-Vitro Diagnostics Market Share in 2022
Figure 31. Global In-Vitro Diagnostics Consumption Value Share by Type (2018-2023)
Figure 32. Global In-Vitro Diagnostics Market Share Forecast by Type (2024-2029)
Figure 33. Global In-Vitro Diagnostics Consumption Value Share by Application (2018-2023)
Figure 34. Global In-Vitro Diagnostics Market Share Forecast by Application (2024-2029)
Figure 35. North America In-Vitro Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 36. North America In-Vitro Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 37. North America In-Vitro Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 38. United States In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 39. Canada In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 40. Mexico In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 41. Europe In-Vitro Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 42. Europe In-Vitro Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 43. Europe In-Vitro Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 45. France In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 46. United Kingdom In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 47. Russia In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 48. Italy In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 49. Asia-Pacific In-Vitro Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 50. Asia-Pacific In-Vitro Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 51. Asia-Pacific In-Vitro Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 52. China In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 53. Japan In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 54. South Korea In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 55. India In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 56. Southeast Asia In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 57. Australia In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 58. South America In-Vitro Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 59. South America In-Vitro Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 60. South America In-Vitro Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 61. Brazil In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 62. Argentina In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 63. Middle East and Africa In-Vitro Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 64. Middle East and Africa In-Vitro Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 65. Middle East and Africa In-Vitro Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 66. Turkey In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 67. Saudi Arabia In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 68. UAE In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 69. In-Vitro Diagnostics Market Drivers
Figure 70. In-Vitro Diagnostics Market Restraints
Figure 71. In-Vitro Diagnostics Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of In-Vitro Diagnostics in 2022
Figure 74. Manufacturing Process Analysis of In-Vitro Diagnostics
Figure 75. In-Vitro Diagnostics Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Roche Abbott Danaher Siemens Healthineers Thermo Fisher Scientific Sysmex BioMerieux Ortho Clinical Diagnostics Becton Dickinson Bio-Rad Laboratories Hologic LifeScan Qiagen Wuhan Easy Diagnosis Wondfo KHB Hotgen Mindray Sinocare Getein Biotech
Related Reports
30 Jan 2023
Medical Care
Product Tags
In Vitro Diagnostics (IVD) Analyzers
In Vitro Diagnostics (IVD) Products and Test
In Vitro Diagnostics Quality Control
In-vitro Diagnostics Packaging
IVD (In Vitro Diagnostics) Products
In-vitro Diagnostics (IVD) Instruments
In Vitro Diagnostics and Cell Culture Medias
In–Vitro Diagnostics (IVDs) Medical Device
In Vitro Diagnostics (IVD) Kits
Animal In Vitro Diagnostics(IVD)
In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases
In Vitro Diagnostics (IVD) Quality Control
In-vitro Diagnostics Instruments
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
